Defibrotide and/or oligodeoxyribonucleotides for treating angiogenesis-dependent tumors

Details for Australian Patent Application No. 2006222044 (hide)

Owner Gentium SpA

Inventors Ferro, Laura Iris; Eissner, Gunter; Iacobelli, Massimo

Agent Griffith Hack

Pub. Number AU-A-2006222044

PCT Pub. Number WO2006/094916

Priority 60/731,404 28.10.05 US; MI2005A000336 03.03.05 IT

Filing date 27 February 2006

Wipo publication date 14 September 2006

International Classifications

A61K 31/711 (2006.01) - Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

13 September 2007 PCT application entered the National Phase

  PCT publication WO2006/094916 Priority application(s): WO2006/094916

20 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006222045-Oligodeoxyribonucleotides of 4000-10000 Dalton for treating tumors

2006222038-Priority-sensitive reallocation of buffer space